glp 1 egfr cut off GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists Kidney Outcomes With Glucagon-Like Peptide-1
Description
Zinman, 2016
Link in comments
Willow focuses entirely on medication
Key strategies include : working with providers to document medical necessity thoroughly in prior authorization requests
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Bitsi S., El Eid L., Manchanda Y., Oqua A.I., Mohamed N., Hansen B., Suba K., Rutter G.A., Salem V., Jones B., et al
